125 related articles for article (PubMed ID: 9641888)
1. Prognostic significance of molecular alterations in human pancreatic carcinoma--an immunohistological study.
Gansauge F; Gansauge S; Schmidt E; Müller J; Beger HG
Langenbecks Arch Surg; 1998 Apr; 383(2):152-5. PubMed ID: 9641888
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of molecular biologogy and immunologic parameters in human pancreatic carcinoma].
Gansauge F; Gansauge S; Müller J; Schmid E; Beger HG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):69-72. PubMed ID: 14518215
[TBL] [Abstract][Full Text] [Related]
3. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
4. Molecular pattern of ductal pancreatic cancer.
Sirivatanauksorn V; Sirivatanauksorn Y; Lemoine NR
Langenbecks Arch Surg; 1998 Apr; 383(2):105-15. PubMed ID: 9641882
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
6. The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas.
Lebe B; Sağol O; Ulukuş C; Coker A; Karademir S; Astarcioglu H; Küpelioğlu A; Astarcioğlu I; Obuz F
Pathol Res Pract; 2004; 200(5):389-96. PubMed ID: 15239347
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer--new aspects of molecular biology research.
Kleeff J; Friess H; Berberat PO; Martignoni ME; Z'graggen K; Büchler MW
Swiss Surg; 2000; 6(5):231-4. PubMed ID: 11077487
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
APMIS; 2014 Dec; 122(12):1230-9. PubMed ID: 25053516
[TBL] [Abstract][Full Text] [Related]
10. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
Wagner U; Süess K; Luginbühl T; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Jordan P; Moch H; Mihatsch MJ; Gasser TC; Sauter G
J Pathol; 1999 May; 188(1):44-50. PubMed ID: 10398139
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival.
Coppola D; Lu L; Fruehauf JP; Kyshtoobayeva A; Karl RC; Nicosia SV; Yeatman TJ
Am J Clin Pathol; 1998 Jul; 110(1):16-23. PubMed ID: 9661918
[TBL] [Abstract][Full Text] [Related]
14. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
16. Desmoplastic reaction influences pancreatic cancer growth behavior.
Hartel M; Di Mola FF; Gardini A; Zimmermann A; Di Sebastiano P; Guweidhi A; Innocenti P; Giese T; Giese N; Büchler MW; Friess H
World J Surg; 2004 Aug; 28(8):818-25. PubMed ID: 15457365
[TBL] [Abstract][Full Text] [Related]
17. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry.
Bachmann K; Neumann A; Hinsch A; Nentwich MF; El Gammal AT; Vashist Y; Perez D; Bockhorn M; Izbicki JR; Mann O
J Surg Oncol; 2015 Mar; 111(3):316-23. PubMed ID: 25470788
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma.
Mukawa K; Kawa S; Aoki Y; Zhai Y; Nikaido T
Am J Gastroenterol; 1999 Aug; 94(8):2263-7. PubMed ID: 10445560
[TBL] [Abstract][Full Text] [Related]
20. Molecular prognostic markers in pancreatic cancer: a systematic review.
Garcea G; Neal CP; Pattenden CJ; Steward WP; Berry DP
Eur J Cancer; 2005 Oct; 41(15):2213-36. PubMed ID: 16146690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
